ACTL7A | Actin-like 7A | Cytoskeleton related proteins
| | | | | Tissue enriched |
FMR1NB | Fragile X mental retardation 1 neighbor | Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
TXNDC2 | Thioredoxin domain containing 2 (spermatozoa) | | | | | | Tissue enriched |
PRSS54 | Protease, serine, 54 | Enzymes Predicted secreted proteins
| | | | | Tissue enriched |
CGB8 | Chorionic gonadotropin, beta polypeptide 8 | Cancer-related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
SELM | Selenoprotein M | Predicted secreted proteins
| | | | | Tissue enriched |
PASD1 | PAS domain containing 1 | | | | | | Tissue enriched |
SMC1B | Structural maintenance of chromosomes 1B | | | | | | Tissue enriched |
ISM2 | Isthmin 2 | Predicted secreted proteins
| | | | | Tissue enriched |
DCT | Dopachrome tautomerase | Enzymes Predicted membrane proteins
| | | | | Tissue enriched |
DAZL | Deleted in azoospermia-like | | | | | | Tissue enriched |
TGIF2LX | TGFB-induced factor homeobox 2-like, X-linked | Transcription factors
| | | | | Tissue enriched |
MAGEA1 | Melanoma antigen family A, 1 (directs expression of antigen MZ2-E) | | | | | | Tissue enriched |
SNCB | Synuclein, beta | | | | | | Tissue enriched |
SAGE1 | Sarcoma antigen 1 | | | | | | Tissue enriched |
NOV | Nephroblastoma overexpressed | Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
CCDC155 | Coiled-coil domain containing 155 | Predicted membrane proteins
| | | | | Tissue enriched |
CABYR | Calcium binding tyrosine-(Y)-phosphorylation regulated | Cytoskeleton related proteins
| | | | | Tissue enriched |
ADAM12 | ADAM metallopeptidase domain 12 | Enzymes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
SLCO1B3 | Solute carrier organic anion transporter family, member 1B3 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enriched |
NR2E1 | Nuclear receptor subfamily 2, group E, member 1 | Nuclear receptors Transcription factors
| | | | | Tissue enriched |
HSD17B1 | Hydroxysteroid (17-beta) dehydrogenase 1 | Enzymes
| | | | | Tissue enriched |
TNR | Tenascin R | Predicted secreted proteins
| | | | | Tissue enriched |
CMTM2 | CKLF-like MARVEL transmembrane domain containing 2 | Predicted membrane proteins
| | | | | Tissue enriched |
YBX2 | Y box binding protein 2 | Transcription factors
| | | | | Tissue enriched |
CGB2 | Chorionic gonadotropin, beta polypeptide 2 | Predicted secreted proteins
| | | | | Tissue enriched |
SYN1 | Synapsin I | Disease related genes Plasma proteins
| | | | | Tissue enriched |
CALB1 | Calbindin 1, 28kDa | | | | | | Tissue enriched |
JPH1 | Junctophilin 1 | Predicted membrane proteins
| | | | | Tissue enriched |
KLHL41 | Kelch-like family member 41 | Cytoskeleton related proteins Plasma proteins
| | | | | Tissue enriched |
BCAN | Brevican | Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
RP11-762I7.5 | Uncharacterized protein | | | | | | Tissue enriched |
AK5 | Adenylate kinase 5 | Enzymes
| | | | | Tissue enriched |
FABP4 | Fatty acid binding protein 4, adipocyte | Cancer-related genes Plasma proteins
| | | | | Tissue enriched |
FCAR | Fc fragment of IgA, receptor for | CD markers Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
LIN28B | Lin-28 homolog B (C. elegans) | | | | | | Tissue enriched |
TEKT5 | Tektin 5 | | | | | | Tissue enriched |
ADA | Adenosine deaminase | Disease related genes Enzymes FDA approved drug targets Plasma proteins
| | | | | Tissue enriched |
CEBPE | CCAAT/enhancer binding protein (C/EBP), epsilon | Transcription factors
| | | | | Tissue enriched |
POU2F3 | POU class 2 homeobox 3 | Transcription factors
| | | | | Tissue enriched |
FDX1 | Ferredoxin 1 | Mitochondrial proteins
| | | | | Tissue enriched |
KCNH1 | Potassium voltage-gated channel, subfamily H (eag-related), member 1 | Predicted membrane proteins Voltage-gated ion channels
| | | | | Tissue enriched |
SV2A | Synaptic vesicle glycoprotein 2A | FDA approved drug targets Predicted membrane proteins
| | | | | Tissue enriched |
NFE2 | Nuclear factor, erythroid 2 | Transcription factors
| | | | | Tissue enriched |
PLCD4 | Phospholipase C, delta 4 | Enzymes
| | | | | Tissue enriched |
AMPH | Amphiphysin | Cancer-related genes
| | | | | Tissue enriched |
BIN1 | Bridging integrator 1 | Disease related genes
| | | | | Tissue enriched |
GAD1 | Glutamate decarboxylase 1 (brain, 67kDa) | Disease related genes Enzymes Potential drug targets
| | | | | Tissue enriched |
GKAP1 | G kinase anchoring protein 1 | | | | | | Tissue enriched |
KRT13 | Keratin 13 | Cancer-related genes Disease related genes Plasma proteins
| | | | | Tissue enriched |